nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.0374	0.0374	CcSEcCtD
Valsartan—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.025	0.025	CcSEcCtD
Valsartan—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0232	0.0232	CcSEcCtD
Valsartan—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0225	0.0225	CcSEcCtD
Valsartan—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0221	0.0221	CcSEcCtD
Valsartan—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0201	0.0201	CcSEcCtD
Valsartan—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.0194	0.0194	CcSEcCtD
Valsartan—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0183	0.0183	CcSEcCtD
Valsartan—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0178	0.0178	CcSEcCtD
Valsartan—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0175	0.0175	CcSEcCtD
Valsartan—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0173	CcSEcCtD
Valsartan—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0169	CcSEcCtD
Valsartan—Infestation—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0169	CcSEcCtD
Valsartan—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.016	0.016	CcSEcCtD
Valsartan—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0159	0.0159	CcSEcCtD
Valsartan—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0153	CcSEcCtD
Valsartan—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0152	CcSEcCtD
Valsartan—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0152	CcSEcCtD
Valsartan—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0152	CcSEcCtD
Valsartan—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0151	CcSEcCtD
Valsartan—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.015	0.015	CcSEcCtD
Valsartan—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Valsartan—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0149	CcSEcCtD
Valsartan—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0141	0.0141	CcSEcCtD
Valsartan—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0138	CcSEcCtD
Valsartan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Valsartan—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Valsartan—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0134	CcSEcCtD
Valsartan—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0133	CcSEcCtD
Valsartan—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0132	CcSEcCtD
Valsartan—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Valsartan—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.013	0.013	CcSEcCtD
Valsartan—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0128	CcSEcCtD
Valsartan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0127	CcSEcCtD
Valsartan—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0121	CcSEcCtD
Valsartan—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0119	CcSEcCtD
Valsartan—Syncope—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0119	CcSEcCtD
Valsartan—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Valsartan—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Valsartan—Cough—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0116	CcSEcCtD
Valsartan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Valsartan—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Valsartan—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Valsartan—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0112	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0112	CcSEcCtD
Valsartan—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.011	0.011	CcSEcCtD
Valsartan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Valsartan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Valsartan—Infection—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0107	CcSEcCtD
Valsartan—Shock—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Valsartan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Valsartan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Valsartan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Valsartan—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0103	CcSEcCtD
Valsartan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00984	0.00984	CcSEcCtD
Valsartan—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00977	0.00977	CcSEcCtD
Valsartan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.0097	0.0097	CcSEcCtD
Valsartan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00963	0.00963	CcSEcCtD
Valsartan—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00961	0.00961	CcSEcCtD
Valsartan—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00951	0.00951	CcSEcCtD
Valsartan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00939	0.00939	CcSEcCtD
Valsartan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00933	0.00933	CcSEcCtD
Valsartan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00932	0.00932	CcSEcCtD
Valsartan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00924	0.00924	CcSEcCtD
Valsartan—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00884	0.00884	CcSEcCtD
Valsartan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00858	0.00858	CcSEcCtD
Valsartan—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00854	0.00854	CcSEcCtD
Valsartan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00796	0.00796	CcSEcCtD
Valsartan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00775	0.00775	CcSEcCtD
Valsartan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00764	0.00764	CcSEcCtD
Valsartan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00739	0.00739	CcSEcCtD
Valsartan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00714	0.00714	CcSEcCtD
Valsartan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00687	0.00687	CcSEcCtD
Valsartan—Rash—Riluzole—amyotrophic lateral sclerosis	0.00681	0.00681	CcSEcCtD
Valsartan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00681	0.00681	CcSEcCtD
Valsartan—Headache—Riluzole—amyotrophic lateral sclerosis	0.00677	0.00677	CcSEcCtD
Valsartan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00642	CcSEcCtD
